• SENSEX
    NIFTY 50
Market

Here’s why Aurobindo Pharma is Axis Securities’ pick of the week

Updated : September 07, 2020 02:13 PM IST

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients.
Axis Securities expects the company’s earnings to grow at a CAGR of 13.5 percent over FY20-FY23E.
Here’s why Aurobindo Pharma is Axis Securities’ pick of the week

You May Also Like

Live TV

recommended for you

Advertisement